Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments

References

• Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Cad Dermatol VenereoAl. 2017;31(2):205–212. doi:10.1111/jdv.13854
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Balato A, Enerbäck C, et al. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397(10275):754–766. doi:10.1016/S0140-6736(21)00184-7
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–271. doi:10.1016/S0140-6736(07)61128-3
   PubMed Web of Science ®Google Scholar
• Shen Q, Liu R, Tan S, et al. Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis. Front Immunol. 2022;13:1089262. doi:10.3389/fimmu.2022.1089262
   PubMed Web of Science ®Google Scholar
• Yiu ZZ, Griffiths CE. Interleukin 17-A inhibition in the treatment of psoriasis. Expert Rev Clin Immunol. 2016;12(1):1–4. doi:10.1586/1744666X.2016.1112739
   PubMed Web of Science ®Google Scholar
• D’Souza LS, Payette MJ. Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis. J Am Acad Dermatol. 2015;72(4):589–598. doi:10.1016/j.jaad.2014.11.028
   PubMed Web of Science ®Google Scholar
• Galloway JB, Hyrich KL, Mercer LK, et al. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology. 2011;50(1):124–131. doi:10.1093/rheumatology/keq242
   PubMed Web of Science ®Google Scholar
• Carmona-Rocha E, Rusiñol L, Puig L. New and emerging oral/topical small-molecule treatments for psoriasis. Pharmaceutics. 2024;16(2):239. doi:10.3390/pharmaceutics16020239
   PubMed Web of Science ®Google Scholar
• Lee WR, Lin YK, Alalaiwe A, et al. Fractional laser-mediated siRNA delivery for mitigating psoriasis-like lesions via IL-6 silencing. Mol Ther Nucleic Acids. 2020;19:240–251. doi:10.1016/j.omtn.2019.11.013
   PubMedGoogle Scholar
• Saw PE, Song EW. siRNA therapeutics: a clinical reality. Sci China Life Sci. 2020;63(4):485–500. doi:10.1007/s11427-018-9438-y
   PubMed Web of Science ®Google Scholar
• Lamb YN. Inclisiran: first Approval [published correction appears in Drugs. 2021 Jun;81(9):1129]. Drugs. 2021;81(3):389–395. doi:10.1007/s40265-021-01473-6
   PubMed Web of Science ®Google Scholar
• Zhu L, Luo J, Ren K. Nucleic acid-based artificial nanocarriers for gene therapy. J Mater Chem B. 2023;11(2):261–279. doi:10.1039/D2TB01179D
   PubMed Web of Science ®Google Scholar
• Ni X, Lai Y. Keratinocyte: a trigger or an executor of psoriasis? J Leukoc Biol. 2020;108(2):485–491. doi:10.1002/JLB.5MR0120-439R
   PubMed Web of Science ®Google Scholar
• Xu N, Brodin P, Wei T, et al. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol. 2011;131(7):1521–1529. doi:10.1038/jid.2011.55
   PubMed Web of Science ®Google Scholar
• Hampton PJ, Jans R, Flockhart RJ, et al. Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (Nuclear Factor of Activated T Cells 2). J Cell Physiol. 2012;227(4):1529–1537. doi:10.1002/jcp.22872
   PubMed Web of Science ®Google Scholar
• Song Y, Chen L, Li Y, et al. Knockdown of TRAF3IP2 suppresses the expression of VEGFA and the proliferation of keratinocytes and vascular endothelial cells. Heliyon. 2019;5(5):e01642. doi:10.1016/j.heliyon.2019.e01642
   PubMed Web of Science ®Google Scholar
• Szegedi K, Sonkoly E, Nagy N, et al. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS. Exp Dermatol. 2010;19(3):269–278. doi:10.1111/j.1600-0625.2010.01066.x
   PubMed Web of Science ®Google Scholar
• Gao Y, Yi X, Ding Y. Combined transcriptomic analysis revealed AKR1B10 played an important role in psoriasis through the dysregulated lipid pathway and overproliferation of keratinocyte. Biomed Res Int. 2017;2017:8717369. doi:10.1155/2017/8717369
   PubMed Web of Science ®Google Scholar
• Zieba BA, Henry L, Lacroix M, et al. The proteasome maturation protein POMP increases proteasome assembly and activity in psoriatic lesional skin. J Dermatol Sci. 2017;88(1):10–19. doi:10.1016/j.jdermsci.2017.04.009
   PubMed Web of Science ®Google Scholar
• Fang Y, C E, Wu S, et al. Circ-IGF1R plays a significant role in psoriasis via regulation of a miR-194-5p/CDK1 axis. Cytotechnology. 2021;73(6):775–785. doi:10.1007/s10616-021-00496-x
   PubMed Web of Science ®Google Scholar
• Liu XB, Li F, Li YQ, et al. Pituitary tumor transforming gene PTTG2 induces psoriasis by regulating vimentin and E-cadherin expression. Int J Clin Exp Pathol. 2015;8(9):10887–10893.
   PubMed Web of Science ®Google Scholar
• Gao J, Chen F, Hua M, et al. Knockdown of lncRNA MIR31HG inhibits cell proliferation in human HaCaT keratinocytes. Biol Res. 2018;51(1):30. doi:10.1186/s40659-018-0181-8
   PubMedGoogle Scholar
• Umegaki-Arao N, Tamai K, Nimura K, et al. Karyopherin alpha2 is essential for rRNA transcription and protein synthesis in proliferative keratinocytes. PLoS One. 2013;8(10):e76416. doi:10.1371/journal.pone.0076416
   PubMed Web of Science ®Google Scholar
• Liao Y, Su Y, Wu R, et al. Overexpression of Wilms tumor 1 promotes IL-1β expression by upregulating histone acetylation in keratinocytes. Int Immunopharmacol. 2021;96:107793. doi:10.1016/j.intimp.2021.107793
   PubMed Web of Science ®Google Scholar
• Kong Y, Wu R, Zhang S, et al. Wilms’ tumor 1-associating protein contributes to psoriasis by promoting keratinocytes proliferation via regulating cyclinA2 and CDK2. Int Immunopharmacol. 2020;88:106918. doi:10.1016/j.intimp.2020.106918
   PubMed Web of Science ®Google Scholar
• Adamo P, Ladomery MR. The oncogene ERG: a key factor in prostate cancer. Oncogene. 2016;35(4):403–414. doi:10.1038/onc.2015.109
   PubMed Web of Science ®Google Scholar
• Kristl J, Slanc P, Krasna M, et al. Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2. Pharm Res. 2008;25(3):521–529. doi:10.1007/s11095-007-9388-z
   PubMed Web of Science ®Google Scholar
• Chen JG, Fan HY, Wang T, et al. Silencing KRT16 inhibits keratinocyte proliferation and VEGF secretion in psoriasis via inhibition of ERK signaling pathway. Kaohsiung J Med Sci. 2019;35(5):284–296. doi:10.1002/kjm2.12034
   PubMed Web of Science ®Google Scholar
• Chang T, Sun L, Wang Y, et al. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis. Exp Dermatol. 2011;20(7):555–560. doi:10.1111/j.1600-0625.2010.01235.x
   PubMed Web of Science ®Google Scholar
• Yang L, Fan X, Cui T, et al. Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17. J Invest Dermatol. 2017;137(10):2168–2176. doi:10.1016/j.jid.2017.05.015
   PubMed Web of Science ®Google Scholar
• Dallaglio K, Marconi A, Truzzi F, et al. E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro. Exp Dermatol. 2013;22(4):255–261. doi:10.1111/exd.12111
   PubMed Web of Science ®Google Scholar
• Luo Y, Pang B, Hao J, et al. Keratin 17 covalently binds to alpha-enolase and exacerbates proliferation of keratinocytes in psoriasis. Int J Biol Sci. 2023;19(11):3395–3411. doi:10.7150/ijbs.83141
   PubMed Web of Science ®Google Scholar
• Yu J, Zhao Q, Wang X, et al. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J Autoimmun. 2022;133:102916. doi:10.1016/j.jaut.2022.102916
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen Y, Cui L, et al. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13(1):81. doi:10.1038/s41419-022-04523-3
   PubMed Web of Science ®Google Scholar
• Ran L-W, Wang H, Lan D, et al. Effect of RNA interference targeting STAT3 gene combined with ultrasonic irradiation and SonoVue microbubbles on proliferation and apoptosis in keratinocytes of psoriatic lesions. Chin Med J. 2018;131(17):2097–2104. doi:10.4103/0366-6999.239297
   PubMed Web of Science ®Google Scholar
• Qin X, Chen C, Zhang Y, et al. Acitretin modulates HaCaT cells proliferation through STAT1- and STAT3-dependent signaling. Saudi Pharm J. 2017;25(4):620–624. doi:10.1016/j.jsps.2017.04.034
   PubMed Web of Science ®Google Scholar
• Huang W, Zheng X, Huang Q, et al. Protein Kinase CK2 promotes proliferation, abnormal differentiation, and proinflammatory cytokine production of keratinocytes via regulation of STAT3 and Akt pathways in psoriasis. Am J Pathol. 2023;193(5):567–578. doi:10.1016/j.ajpath.2023.01.016
   PubMed Web of Science ®Google Scholar
• Lerman G, Volman E, Sidi Y, et al. Small-interfering RNA targeted at antiapoptotic mRNA increases keratinocyte sensitivity to apoptosis. Br J Dermatol. 2011;164(5):947–956. doi:10.1111/j.1365-2133.2010.10191.x
   PubMed Web of Science ®Google Scholar
• Tonel G, Conrad C. Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis. Int J Biochem Cell Biol. 2009;41(5):963–968. doi:10.1016/j.biocel.2008.10.022
   PubMed Web of Science ®Google Scholar
• Zhu H, Hou L, Liu J, et al. MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2. Biochem Biophys Res Commun. 2016;471(1):169–176. doi:10.1016/j.bbrc.2016.01.157
   PubMed Web of Science ®Google Scholar
• Jeon S, Song J, Lee D, et al. Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice. J Lipid Res. 2020;61(1):20–32. doi:10.1194/jlr.RA119000254
   PubMed Web of Science ®Google Scholar
• Hong JH, Youm JK, Kwon MJ, et al. K6PC-5, a direct activator of sphingosine kinase 1, promotes epidermal differentiation through intracellular Ca2+ signaling. J Invest Dermatol. 2008;128(9):2166–2178. doi:10.1038/jid.2008.66
   PubMed Web of Science ®Google Scholar
• Xu D, Wang J. Downregulation of cathepsin B reduces proliferation and inflammatory response and facilitates differentiation in human HaCaT keratinocytes, ameliorating IL-17A and SAA-induced psoriasis-like lesion. Inflammation. 2021;44(5):2006–2017. doi:10.1007/s10753-021-01477-0
   PubMed Web of Science ®Google Scholar
• Lian N, Chen Y, Chen S, et al. Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis. Cell Death Dis. 2023;14(9):595. doi:10.1038/s41419-023-06094-3
   PubMed Web of Science ®Google Scholar
• Yamamoto T. Angiogenic and inflammatory properties of psoriatic arthritis. ISRN Dermatol. 2013;2013:630620. doi:10.1155/2013/630620
   PubMedGoogle Scholar
• Patel AB, Tsilioni I, Weng Z, et al. TNF stimulates IL-6, CXCL 8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin. Exp Dermatol. 2018;27(2):135–143. doi:10.1111/exd.13461
   PubMed Web of Science ®Google Scholar
• Benhadou F, Glitzner E, Brisebarre A, et al. Epidermal autonomous VEGFA/Flt1/Nrp1 functions mediate psoriasis-like disease. Sci Adv. 2020;6(2):eaax5849. doi:10.1126/sciadv.aax5849
   PubMed Web of Science ®Google Scholar
• Nicchia GP, Stigliano C, Sparaneo A, et al. Inhibition of aquaporin-1 dependent angiogenesis impairs tumour growth in a mouse model of melanoma. J Mol Med. 2013;91(5):613–623. doi:10.1007/s00109-012-0977-x
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma WY. Nerve growth factor regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes via PI3K/mTOR pathway. Genet Mol Res. 2014;13(4):9324–9335. doi:10.4238/2014.January.24.14
   PubMed Web of Science ®Google Scholar
• Niu X, Han Q, Li X, et al. EDIL3 influenced the αvβ3-FAK/MEK/ERK axis of endothelial cells in psoriasis. J Cell Mol Med. 2022;26(20):5202–5212. doi:10.1111/jcmm.17544
   PubMed Web of Science ®Google Scholar
• Ghosh D, Ganguly T, Chatterjee R. Emerging roles of non-coding RNAs in psoriasis pathogenesis. Funct Integr Genomics. 2023;23(2):129. doi:10.1007/s10142-023-01057-5
   PubMed Web of Science ®Google Scholar
• Grän F, Kerstan A, Serfling E, et al. Current developments in the immunology of psoriasis. Yale J Biol Med. 2020;93(1):97–110. doi:10.1038/jid.2012.339
   PubMed Web of Science ®Google Scholar
• Ding Y, Gong P, Jiang J, et al. Mesenchymal stem/stromal cells primed by inflammatory cytokines alleviate psoriasis-like inflammation via the TSG-6-neutrophil axis. Cell Death Dis. 2022;13(11):996. doi:10.1038/s41419-022-05445-w
   PubMed Web of Science ®Google Scholar
• Chen F, Wu S, Zhan J, et al. IL-22-induced ubiquitin-specific protease 15 promotes proliferation and inflammation of keratinocytes through stabilization of squamous cell carcinoma antigen 2. J Invest Dermatol. 2024;144(1):63–72.e4. doi:10.1016/j.jid.2023.07.006
   PubMed Web of Science ®Google Scholar
• Xiao CY, Zhu ZL, Zhang C, et al. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis. Chin Med J. 2020;133(24):2910–2918. doi:10.1097/CM9.0000000000001197
   PubMed Web of Science ®Google Scholar
• Bertelsen T, Ljungberg C, Boye Kjellerup R, et al. IL-17F regulates psoriasis-associated genes through IκBζ. Exp Dermatol. 2017;26(3):234–241. doi:10.1111/exd.13182
   PubMed Web of Science ®Google Scholar
• Bertelsen T, Iversen L, Johansen C. The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ. Exp Dermatol. 2018;27(9):1048–1052. doi:10.1111/exd.13722
   PubMed Web of Science ®Google Scholar
• Johansen C, Mose M, Ommen P, et al. IκBζ is a key driver in the development of psoriasis. Proc Natl Acad Sci U S A. 2015;112(43):E5825–E5833. doi:10.1073/pnas.1509971112
   PubMed Web of Science ®Google Scholar
• Wang A, Wei J, Lu C, et al. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes. Int Immunopharmacol. 2019;69:270–278. doi:10.1016/j.intimp.2019.01.054
   PubMed Web of Science ®Google Scholar
• Fan T, Wang S, Yu L, et al. Treating psoriasis by targeting its susceptibility gene Rel. Clin Immunol. 2016;165:47–54. doi:10.1016/j.clim.2016.03.009
   PubMed Web of Science ®Google Scholar
• Gao Y, Lu J, Bao X, et al. Inhibition of phospholipases suppresses progression of psoriasis through modulation of inflammation. Exp Biol Med. 2021;246(11):1253–1262. doi:10.1177/1535370221993424
   Web of Science ®Google Scholar
• Xiang X, Tu C, Li Q, et al. Oxymatrine ameliorates imiquimod-induced psoriasis pruritus and inflammation through inhibiting Heat Shock Protein 90 and Heat Shock Protein 60 expression in keratinocytes. Toxicol Appl Pharmacol. 2020;405:115209. doi:10.1016/j.taap.2020.115209
   PubMed Web of Science ®Google Scholar
• Hsieh WL, Huang YH, Wang TM, et al. IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes. Cell Prolif. 2015;48(2):187–197. doi:10.1111/cpr.12168
   PubMed Web of Science ®Google Scholar
• Deng Y, Chen J, Zhao Y, et al. Transdermal Delivery of siRNA through Microneedle Array. Sci Rep. 2016;6(1):21422. doi:10.1038/srep21422
   PubMedGoogle Scholar
• Dharamdasani V, Mandal A, Qi QM, et al. Topical delivery of siRNA into skin using ionic liquids. J Control Release. 2020;323:475–482. doi:10.1016/j.jconrel.2020.04.038
   PubMed Web of Science ®Google Scholar
• Mandal A, Kumbhojkar N, Reilly C, et al. Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations. Sci Adv. 2020;6(30):eabb6049. doi:10.1126/sciadv.abb6049
   PubMed Web of Science ®Google Scholar
• Hsu T, Mitragotri S. Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer. Proc Natl Acad Sci U S A. 2011;108(38):15816–15821. doi:10.1073/pnas.1016152108
   PubMed Web of Science ®Google Scholar
• Desmet E, Van Gele M, Grine L, Remaut K, Lambert J. Towards the development of a RNAi-based topical treatment for psoriasis: proof-of-concept in a 3D psoriasis skin model. Exp Dermatol. 2018;27(5):463–469. doi:10.1111/exd.13414
   PubMed Web of Science ®Google Scholar
• Feng AP, He YM, Liu XX, et al. Expression of USP15, TβR-I and Smad7 in psoriasis. J Huazhong Univ Sci Technolog Med Sci. 2014;34(3):415–419. doi:10.1007/s11596-014-1293-1
   PubMedGoogle Scholar
• Vaher H, Kivihall A, Runnel T, et al. SERPINB2 and miR-146a/b are coordinately regulated and act in the suppression of psoriasis-associated inflammatory responses in keratinocytes. Exp Dermatol. 2020;29(1):51–60. doi:10.1111/exd.14049
   PubMed Web of Science ®Google Scholar
• Rooney P, Connolly M, Gao W, et al. Notch-1 mediates endothelial cell activation and invasion in psoriasis. Exp Dermatol. 2014;23(2):113–118. doi:10.1111/exd.12306
   PubMed Web of Science ®Google Scholar
• Ji X, Chen H, Xie L, et al. The study of GSDMB in pathogenesis of psoriasis vulgaris. PLoS One. 2023;18(1):e0279908. doi:10.1371/journal.pone.0279908
   PubMed Web of Science ®Google Scholar
• Li R, Wang J, Wang X, et al. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway. Gene. 2016;592(1):164–171. doi:10.1016/j.gene.2016.07.066
   PubMed Web of Science ®Google Scholar
• Kaikai S, Yuchen S, Lili J, Zhengtao W. Critical role of c-Jun N-terminal kinase in regulating bFGF-induced angiogenesis in vitro. J Biochem. 2011;150(2):189–197. doi:10.1093/jb/mvr060
   PubMed Web of Science ®Google Scholar
• Ezure T, Amano S. Stanniocalcin-1 mediates negative regulatory action of epidermal layer on expression of matrix-related genes in dermal fibroblasts. Biofactors. 2019;45(6):944–949. doi:10.1002/biof.1547
   PubMed Web of Science ®Google Scholar
• Qiu X, Zheng L, Liu X, et al. ULK1 inhibition as a targeted therapeutic strategy for psoriasis by regulating keratinocytes and their crosstalk with neutrophils. Front Immunol. 2021;12:714274. doi:10.3389/fimmu.2021.714274
   PubMed Web of Science ®Google Scholar
• Xu M, Zhang Y, Cheng H, et al. Transcription factor 7-like 1 dysregulates keratinocyte differentiation through upregulating lipocalin 2. Cell Death Discov. 2016;2(1):16028. doi:10.1038/cddiscovery.2016.28
   PubMed Web of Science ®Google Scholar
• Vegfors J, Ekman AK, Stoll SW, Bivik Eding C, Enerbäck C. Psoriasin (S100A7) promotes stress-induced angiogenesis. Br J Dermatol. 2016;175(6):1263–1273. doi:10.1111/bjd.14718
   PubMed Web of Science ®Google Scholar
• Wang H, Ran LW, Hui K, et al. Survivin 和PI3K、AKT在寻常型银屑病皮损角质形成细胞中的表达及其相关性 [Expressions of survivin, PI3K and AKT in keratinocytes in skin lesions and their pathogenic role in psoriasis vulgaris]. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37(11):1512–1516. Chinese. doi:10.3969/j.issn.1673-4254.2017.11.14
   PubMedGoogle Scholar
• Tu C, Wang S, Hu X, et al. Lipopolysaccharide induces TREM-1-dependent HIF-1α expression in human keratinocyte cell line. Cell Biol Int. 2016;40(12):1357–1365. doi:10.1002/cbin.10693
   PubMed Web of Science ®Google Scholar
• Koegel H, von Tobel L, Schäfer M, et al. Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J Clin Invest. 2009;119(4):899–910. doi:10.1172/JCI37771
   PubMed Web of Science ®Google Scholar
• Gargalionis AN, Malakou LS, Adamopoulos C, et al. Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis. Biochim Biophys Acta Mol Basis Dis. 2018;1864(10):3468–3476. doi:10.1016/j.bbadis.2018.07.036
   PubMed Web of Science ®Google Scholar
• Tian R, Li Y, Yao X. PGRN Suppresses Inflammation and Promotes Autophagy in Keratinocytes Through the Wnt/β-Catenin Signaling Pathway. Inflammation. 2016;39(4):1387–1394. doi:10.1007/s10753-016-0370-y
   PubMed Web of Science ®Google Scholar
• Shan Y, Zhao J, Wei K, et al. A comprehensive review of Tripterygium wilfordii hook. f. in the treatment of rheumatic and autoimmune diseases: bioactive compounds, mechanisms of action, and future directions. Front Pharmacol. 2023;14:1282610. doi:10.3389/fphar.2023.1282610
   PubMed Web of Science ®Google Scholar
• Camela E, Potestio L, Fabbrocini G, Pallotta S, Megna M. The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs. Expert Opin Investig Drugs. 2023;32(6):537–552. doi:10.1080/13543784.2023.2219387
   PubMed Web of Science ®Google Scholar